Amodiaquine/Artesunate
- Generic Name
- Amodiaquine/Artesunate
Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali
Phase 1
Completed
- Conditions
- Malaria
- Interventions
- Biological: PfSPZ VaccineBiological: PfSPZ Challenge MaterialOther: Normal SalineDrug: PBS and HSA Diluent
- First Posted Date
- 2015-12-11
- Last Posted Date
- 2021-04-21
- Target Recruit Count
- 409
- Registration Number
- NCT02627456
- Locations
- 🇲🇱
University of Bamako (USTTB/MRTC), Bamako, Mali
ANC & Malaria Diagnostic in Pregnancy
- First Posted Date
- 2012-10-11
- Last Posted Date
- 2015-07-31
- Lead Sponsor
- Centre Muraz
- Target Recruit Count
- 5254
- Registration Number
- NCT01703884
- Locations
- 🇧🇫
Dafra & Do districts, Bobo-Dioulasso, Hauts Bassins-houet, Burkina Faso
Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2010-06-29
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 413
- Registration Number
- NCT00699920
- Locations
- 🇺🇬
Sanofi-aventis administrative office, Kampala, Uganda
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath